Davide Leone & Partners Investment Company’s St Jude Medical STJ Stock Holding History

Davide Leone & Partners Investment Company’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-192,000	Closed	-$15.4M	–	17
2016 Q4	$15.4M	Buy	+192,000	New	+$15.2M	1.84%	13

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Davide Leone & Partners Investment Company's STJ Position: Q1 2017 in Review

Davide Leone & Partners Investment Company sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 192,000 shares — an estimated $15.4M sold.

Davide Leone & Partners Investment Company first reported a position in STJ in Q4 2016 and held it in 1 quarter. The position peaked at $15.4M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Davide Leone & Partners Investment Company reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Davide Leone & Partners Investment Company sold 192,000 St Jude Medical shares in Q1 2017, an estimated $15.4M.
Davide Leone & Partners Investment Company first reported a position in St Jude Medical in Q4 2016 and held it in 1 quarter.
Davide Leone & Partners Investment Company's St Jude Medical position peaked at $15.4M in Q4 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Davide Leone & Partners Investment Company's 13F filing for Q1 2017, filed 15 May 2017.